J Pan, Z Li, C Ye, X Zhang, Q Yang… - … and Clinical Risk …, 2025 - Taylor & Francis
Objective Mesalazine is a widely used medication for treating mild to moderate inflammatory
bowel disease (IBD). First identified as a potential cause of acute pancreatitis (AP) in 1989 …